NVIDIA and Lilly Join Forces to Transform Drug Discovery With AI

NVIDIA and Eli Lilly announced the launch of a first-of-its-kind AI co-innovation lab at the J.P. Morgan Healthcare Conference. The partnership includes a $1 billion investment over a five-year period. Lilly brings deep expertise in drug research, while NVIDIA provides advanced AI computing capabilities. Together, they aim to speed up drug discovery using simulations, AI models, and close collaboration between humans and machines.